Last reviewed · How we verify
NCT06167668
The Influence of Internet + Combined Family Empowerment Management Mode on Treatment Compliance of PATIENTS With CKD
trial testing the routine chronic disease management mode in Internet in 100 participants. Status unknown.
24 July 2024
Quick facts
| Lead sponsor | Shanxi Medical University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 23 November 2023 |
| Primary completion | 24 July 2024 |
| Estimated completion | 24 November 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- the routine chronic disease management mode
- the family-centered family enabling health management mode
Conditions studied
- Internet — all drugs for Internet →
- Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
Sponsor
Shanxi Medical University
Who can join
Adults 40 to 60, any sex, with Internet or Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the effect of Internet + combined family empowerment management mode on treatment compliance of patients with chronic kidney disease (CKD) and the correlation between psychological status and disease progression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06167668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Internet
Currently open trials in the same condition.
- NCT03335644 — The NutriNet-Santé Study · recruiting
Other Shanxi Medical University trials
Trials by the same sponsor.
- NCT06175585 — Construction of Theoretical Model of Medical Treatment Behavior of Patients With Chronic Kidney Disease · unknown
- NCT05099757 — The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06167668 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanxi Medical University
- Last refreshed: 22 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing